Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Blackhall

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Immunology, Immunotherapy : CII|September 11, 2020
Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancerH Adderley, F H Blackhall, C R Lindsay
British Journal of Cancer|November 17, 2001
Heparan sulfate proteoglycans and cancerF H Blackhall, C L Merry, E J Davies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2020
Germline and sporadic cancers driven by the RAS pathway: parallels and contrastsV Dunnett-Kane, E Burkitt-Wright, F H Blackhall, et al.
British Journal of Cancer|October 2, 2003
A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinomaA R Clamp, F H Blackhall, P Vasey, et al.
British Journal of Cancer|March 23, 2013
Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patientsR Stovold, S L Meredith, J L Bryant, et al.
British Journal of Cancer|March 27, 2001
A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphomaF H Blackhall, M Ranson, J A Radford, et al.
British Journal of Cancer|August 15, 2002
Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin's diseaseF H Blackhall, A D Atkinson, M B Maaya, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2009
The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials UnitP Wheatley-Price, C Ma, L F Ashcroft, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2016
Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case studyC J Morrow, F Trapani, R L Metcalf, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2019
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancerC R Lindsay, F H Blackhall, A Carmel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Immunology, Immunotherapy : CII|September 11, 2020
Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancerH Adderley, F H Blackhall, C R Lindsay
British Journal of Cancer|November 17, 2001
Heparan sulfate proteoglycans and cancerF H Blackhall, C L Merry, E J Davies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2020
Germline and sporadic cancers driven by the RAS pathway: parallels and contrastsV Dunnett-Kane, E Burkitt-Wright, F H Blackhall, et al.
British Journal of Cancer|October 2, 2003
A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinomaA R Clamp, F H Blackhall, P Vasey, et al.
British Journal of Cancer|March 23, 2013
Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patientsR Stovold, S L Meredith, J L Bryant, et al.
British Journal of Cancer|March 27, 2001
A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphomaF H Blackhall, M Ranson, J A Radford, et al.
British Journal of Cancer|August 15, 2002
Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin's diseaseF H Blackhall, A D Atkinson, M B Maaya, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 14, 2009
The strength of female sex as a prognostic factor in small-cell lung cancer: a pooled analysis of chemotherapy trials from the Manchester Lung Group and Medical Research Council Clinical Trials UnitP Wheatley-Price, C Ma, L F Ashcroft, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2016
Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case studyC J Morrow, F Trapani, R L Metcalf, et al.
European Journal of Cancer (Oxford, England : 1990)|June 30, 2019
EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancerC R Lindsay, F H Blackhall, A Carmel, et al.
Pageof 1